Product Information
FYCOMPA 4 MG TABLET is a brand product labeled by Catalyst Pharmaceuticals, Inc., priced at $39.1187 per EA under NDC 69616027430. Its NADAC has been published 125 times since Feb 7, 2024.
Strength
4 mg/1
Manufacturer
Catalyst Pharmaceuticals, Inc.NDC
69616027430
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PERAMPANELApproval Type
New Drug (NDA)
FDA Application
NDA202834On Market Since
1/2/2024
Pharmacological Classes
Price Statistics
The NADAC for FYCOMPA 4 MG TABLET has been published 125 times since Feb 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.1187 per EA |
|---|---|
| All-time high | $39.3206 (Sep 11, 2024) |
| All-time low | $39.1187 (Jun 17, 2026) |
| 52-week high | $39.2544 |
| 52-week low | $39.1187 |
| Median price | $39.2101 |
| Average price | $39.2169 |
| Largest weekly change | +0.2% (May 22, 2024) |
| Weeks tracked | 125 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FYCOMPA 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 4 MG TABLET, manufactured by Catalyst Pharmaceuticals, Inc., is $39.1187 per EA (NDC 69616027430), effective Jun 24, 2026.
How has the price of FYCOMPA 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for FYCOMPA 4 MG TABLET has held within roughly two percent of its current level. It has been tracked across 125 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for FYCOMPA 4 MG TABLET?
Since Feb 7, 2024, the NADAC for FYCOMPA 4 MG TABLET has ranged from a low of $39.1187 (Jun 17, 2026) to a high of $39.3206 (Sep 11, 2024), with a median of $39.2101 per EA.
Are there cheaper alternatives to FYCOMPA 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FYCOMPA 4 MG TABLET, but none are currently priced below it.
Who manufactures FYCOMPA 4 MG TABLET?
FYCOMPA 4 MG TABLET (NDC 69616027430) is labeled by Catalyst Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification